Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents. 2019

Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, People's Republic of China.

Twenty-four 1,2-diarylbenzimidazole derivatives were designed, synthesized and biologically evaluated. It turned out that most of them were potential anticancer drugs. Among them, compound c24 showed the highest anti-tumor activity (GI50 = 0.71-2.41 μM against HeLa, HepG2, A549 and MCF-7 cells), and low toxicity to normal cells (CC50 > 100 μM against L02 cells). In the microtubule binding assay, c24 showed the most potent inhibition of microtubule polymerization (IC50 = 8.47 μM). The binding ability of compound c24 to tubulin crystal was verified by molecular docking simulation experiment. Further studies on HepG2 and HeLa cells showed that compound c24 could cause mitotic arrest of tumor cells to G2/M phase then inducing apoptosis. To sum up, compound c24 is a promising microtubule assembly inhibitor.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
March 2015, European journal of medicinal chemistry,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
November 2023, Molecular diversity,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
September 2022, Molecules (Basel, Switzerland),
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
November 2023, Archiv der Pharmazie,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
January 2007, Bioorganic & medicinal chemistry letters,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
August 2023, Chemical biology & drug design,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
August 2018, Bioorganic chemistry,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
December 2020, Bioorganic & medicinal chemistry letters,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
December 2016, Bioorganic chemistry,
Ya-Liang Zhang, and Rong Yang, and Lin-Ying Xia, and Ruo-Jun Man, and Yi-Chun Chu, and Ai-Qin Jiang, and Zhong-Chang Wang, and Hai-Liang Zhu
May 2023, International journal of molecular sciences,
Copied contents to your clipboard!